3.22

2.72% -0.09

After Hours: 3.22

Precigen Inc (PGEN)

Overview News Price History Option Chain Financials Discussions Forecast

Precigen Inc stock is traded at $3.22, with a volume of 5.17M. It is down -2.72% in the last 24 hours and down -22.60% over the past month. Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Previous Close:

$3.31

Open:

$3.33

24h Volume:

5.17M

Relative Volume:

0.60

Market Cap:

$959.47M

Revenue:

$6.23M

Net Income/Loss:

$-95.90M

P/E Ratio:

-8.2564

EPS:

-0.39

Net Cash Flow:

$-68.47M

1W Performance:

-3.59%

1M Performance:

-22.60%

6M Performance:

+175.21%

1Y Performance:

+276.26%

1-Day Range:

$3.205

$3.425

1-Week Range:

$3.08

$3.425

52-Week Range:

$0.6513

$5.225

Precigen Inc Stock (PGEN) Company Profile

Name

Precigen Inc

Sector

Healthcare (1141)

Industry

Biotechnology (637)

Phone

301-556-9900

Address

20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD

Employee

Twitter

@precigen

Next Earnings Date

2025-03-19

Latest SEC Filings

PGEN's Discussions on Twitter

Compare PGEN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PGEN Precigen Inc	3.22	1.17B	6.23M	-95.90M	-68.47M	-0.39
VRTX Vertex Pharmaceuticals Inc	421.15	105.19B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	450.68	60.24B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	563.86	61.82B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	798.94	49.09B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	351.09	37.52B	4.56B	-176.77M	225.30M	-1.7177

Precigen Inc Stock (PGEN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-15-25	Upgrade	JP Morgan	Underweight → Neutral
Mar-22-24	Downgrade	JP Morgan	Neutral → Underweight
May-23-23	Initiated	JP Morgan	Neutral
Nov-18-22	Initiated	Cantor Fitzgerald	Overweight
Feb-25-21	Initiated	Stifel	Buy
Feb-22-21	Initiated	Wells Fargo	Overweight
Feb-18-21	Initiated	B. Riley Securities	Buy
May-08-20	Initiated	H.C. Wainwright	Buy

View All

Precigen Inc Stock (PGEN) Latest News

04:48 AM

Precigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

04:48 AM

Oct 07, 2025

Precigen (NASDAQ:PGEN) Trading 5.6% HigherStill a Buy? - MarketBeat

Oct 07, 2025

Oct 06, 2025

Chart based analysis of Precigen Inc. trends2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - newser.com

Oct 06, 2025

How Precigen Inc. stock performs in high volatility marketsJuly 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - newser.com

Oct 06, 2025

Is Precigen Inc. stock ready for a breakoutJuly 2025 Highlights & AI Forecast Swing Trade Picks - newser.com

Oct 06, 2025

Oct 05, 2025

Why Precigen Inc. stock is seen as undervalued2025 Retail Activity & Reliable Volume Spike Trade Alerts - newser.com

Oct 05, 2025

Will Precigen Inc. stock deliver long term returnsEarnings Performance Report & Capital Efficiency Focused Ideas - newser.com

Oct 05, 2025

Will Precigen Inc. stock deliver consistent dividendsJuly 2025 Setups & Detailed Earnings Play Alerts - newser.com

Oct 05, 2025

Volatility clustering patterns for Precigen Inc.July 2025 Patterns & Free Community Consensus Stock Picks - newser.com

Oct 05, 2025

Oct 04, 2025

Critical Analysis: Precigen (NASDAQ:PGEN) and Entera Bio (NASDAQ:ENTX) - Defense World

Oct 04, 2025

Oct 03, 2025

What machine learning models say about Precigen Inc.July 2025 Weekly Recap & Fast Entry and Exit Trade Plans - newser.com

Oct 03, 2025

Oct 01, 2025

These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts - MSN

Oct 01, 2025

Insider Sell: Jeffrey Kindler Sells 174,360 Shares of Precigen I - GuruFocus

Oct 01, 2025

Jeffrey Kindler Sells 106,837 Shares of Precigen (NASDAQ:PGEN) Stock - MarketBeat

Oct 01, 2025

Precigen Signs a Credit Facility Agreement Worth $125 Million to Support PAPZIMEOS - MSN

Oct 01, 2025

Sep 30, 2025

Is Precigen Inc a good long term investmentEarnings Growth Projections & Free Realize Exceptional Returns - earlytimes.in

Sep 28, 2025

Sep 27, 2025

What drives Precigen Inc stock priceEarnings Revision Updates & Rapid Profit Growth - Early Times

Sep 27, 2025

Precigen stock rating reiterated as Overweight by Cantor Fitzgerald By Investing.com - Investing.com Nigeria

Sep 27, 2025

Sep 26, 2025

Precigen CFO Thomasian buys shares worth $40,015 By Investing.com - Investing.com Nigeria

Sep 26, 2025

Precigen (NASDAQ:PGEN) CFO Harry Jr. Thomasian Buys 2,932 Shares - MarketBeat

Sep 26, 2025

Harry Jr. Thomasian Acquires 8,284 Shares of Precigen (NASDAQ:PGEN) Stock - MarketBeat

Sep 26, 2025

Precigen CFO Thomasian buys shares worth $40,015 - Investing.com India

Sep 26, 2025

Insider Buying: Harry Thomasian Acquires Shares of Precigen Inc (PGEN) - GuruFocus

Sep 26, 2025

Precigen, Inc. Hits Day Low of $3.47 Amid Price Pressure - Markets Mojo

Sep 26, 2025

Precigen stock rating reiterated as Overweight by Cantor Fitzgerald - Investing.com Australia

Sep 26, 2025

Goldman Sachs Group Inc. Has $497,000 Holdings in Precigen, Inc. $PGEN - MarketBeat

Sep 26, 2025

Sep 25, 2025

Precigen (NASDAQ:PGEN) Trading Down 6.1%Time to Sell? - MarketBeat

Sep 25, 2025

Sep 23, 2025

PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug - MSN

Sep 23, 2025